The programme of the pre-meeting courses are available.

Please note that the pre-meeting courses will take place onsite.

To register for a pre-meeting course please select the pre-meeting of your choice as an ''add-on" in your registration. 

If you are only attending a pre-meeting, and not the full congress, please select the fee "No-days" and then select the pre-meeting course of your choice.

 

Multidisciplinary approach to high-risk skin cancer with special focus on brachytherapy

Friday 6 May 2022
09:00-17:00

The course has been prepared under BT track but it covers general information on multidisciplinary management of skin cancer and includes also external beam radiotherapy and systemic treatments with immunotherapy.

Course Directors

  • Agata Rembielak, Radiation Oncologist and Clinical Oncologist, The Christie Hospital and The University of Manchester, Manchester (UK)
  • Luca Tagliaferri, Radiation Oncologist, Fondazione Policlinico Universitario «Agostino Gemelli» IRCCS, Rome (IT)

Course aim

The aim of this one-day pre-meeting course is to share expertise, best practices and to provide a state-of-the-art critical overview of selected developments in the management of non-melanoma skin cancer. The main focus will be on skin brachytherapy, but the event will also provide perspective from other health care professionals involved in the management of skin cancer.

Learning objectives

By the end of this course participants should be able to:

  • Understanding of epidemiology and pathology of skin cancer with special focus on mutational burden and genetic profiling
  • Have a general knowledge of surgical management and reconstruction techniques in skin cancer
  • Summarise the role of skin radiotherapy and brachytherapy in skin cancer in view of recently published guidelines and metaanalysis
  • Develop a deep understanding of best practices in superficial and interstitial skin brachytherapy
  • Demonstrate increased awareness of geriatric assessment and skin of the colour issues in skin cancer management
  • Understand the role of RTTs and nurses in skin cancer treatment
  • Summarise the latest technical developments in skin radiotherapy and brachytherapy
  • Discuss the potential of artificial intelligence, Big Data and PROMs to enhance personalize medicine and access to radiotherapy

Who should attend?

This pre-meeting course is aimed at radiation oncologist / clinical oncologists, medical physicists and RTTs, at senior and trainee level, who are involved in the management of non-melanoma skin cancer, particularly in skin brachytherapy. The course may also be of interest to other health care professionals involved in skin cancer treatment and would like an overview of current developments in dermatooncology and skin radiotherapy / brachytherapy. 

Accreditation

The course has been granted 5 European CME credits (ECMEC®s) by the European Accreditation Council for Continuing Medical Education (EACCME®).

Programme

Available here

Integration of radiotherapy into targeted or immunotherapy

Friday 6 May 2022
08:30-18:00

Course directors

  • Timothy Illidge, University of Manchester, Christie Hospital NHS Foundation Trust (UK)
  • Eric Deutsch, Head of the Radiation Oncology Department, Institut de cancĂ©rologie Gustave Roussy (FR)

Course aims

  • Provide a general introduction to tumour immunology
  • provide an outline of the interplay between radiotherapy and immune system
  • Understand emerging mechanisms of response and resistance to RT and immune checkpoint inhibitors  
  • Outline novel therapeutic approaches to overcoming therapeutic resistance – moving beyond immune checkpoint inhibitors
  • To discuss progress and uncertainties of the immunoregulatory effects of Radiotherapy planning including volume, dose and fractionation  

Learning objectives

  • An introduction to tumour immunolog
  • An introduction to the complexities of the immunomodulatory properties of radiotherapy
  • To gain an understanding of the current Clinical landscape of progress and challenges with radiotherapy and Immuno-Oncology agents combinations
  • To understand therapeutic opportunities in combining RT and Immune oncology agents to inform future clinical design

Who should attend?

Radiation oncologists (faculty and trainees), scientists, medical physicists, medical oncologists.

Accreditation

The course has been granted 5 European CME credits (ECMEC®s) by the European Accreditation Council for Continuing Medical Education (EACCME®).

Programme

Available here.

Innovative models to assess efficacy and toxicity treatment combination with radiotherapy

Friday, 6 May 2022
08:30-17:00

Course directors

  • François Paris, Radiobiologist, CRCI2NA / INSERM UMR1307/ CNRS 6075 (FR)
  • Rob Coppes, Radiobiologist,  Department of Biomedical Sciences of Cells & Systems, FB30, Section Molecular Cell; Biology Department of Radiation Oncology, University Medical Center Groningen, University of Groningen (NL)

Course aim

To understand the importance and to define the limitations of new preclinical multicellular models that better represent the structural complexity of tumours or healthy tissues in order to study the radiobiological mechanism of treatment efficacy and toxicity and their potential application in the clinic.

The course will provide insight in the most recent developed 3D-models of different tissue and cancers, patients specific approached for personalized medicine and how to interpret and translate these to the clinic.

Learning objectives

By the end of this course participants should be able to:

  • To raise awareness and understand 3D-models for use in radiation research
  • To understand how to analyse 3D derived complex data sets.
  • To obtain handholds to further develop such models
  • To be able to translate such model to the clinic.

Who should attend?

  • Medical physicists and radiation oncologists interested in learning about how personal bio-medicine can be applied in radiation research
  • Radiobiologist interested in the use of 3D models and analyses.
  • Radiation biologists, physicist and oncologist seeking information on how to choose the best model and identify the relevant questions.

Multidisciplinary teams are also welcome.

Accreditation

The course has been granted 5 European CME credits (ECMEC®s) by the European Accreditation Council for Continuing Medical Education (EACCME®).

Programme

Available here.

Time to adapt: Future role of the RTT

Friday 6 May 2022
08:30 -17:00

Course directors

  • Yatman Tsang, Radiation Therapist, Mount Vernon Hospital (UK)
  • Philipp Scherer, Radiation Therapist, Salzburger Landeskliniken (AU)

Course aim

The course is directed at RTTs and professionals either interested in progressing into educational and management roles in radiotherapy; or developing/leading a team of clinical RTTs with advanced practice RTTs. The course aims to facilitate scientific collaborations and professional networking within the ESTRO RTT membership and community allow networking with other RTTs research active in research and encourage future collaborations

Learning objectives

By the end of this course participants should be able:

  • To adopt a critical approach of how to evaluate the RTT education curriculum and its impact on scopes of practice.
  • To understand the basic principles of how to develop and lead the implementation of a RTT specific education and training programme.
  • To effectively evaluate the current trends of RTT advanced practice and discuss potential challenges and bottlenecks for future progression opportunities

Who should attend?

  • RTT managers, advanced practitioners and educators who are highly motivated to define the future of the RTT profession and the underpinning education programmes. 
  • RTTs/ healthcare professionals who are interested in extending the RTT scope of practice. Possibly, but not necessarily, they have >3 years clinical experience.
  • RTTs/ healthcare professionals who want to develop leadership, management, teaching and research skills.
  • RTTs/ healthcare professionals who want to be more involved in education and training framework.

Programme

Available here

Real-world implementation of adaptive radiotherapy in clinical practice

Friday 6 May 2022 
8:30 - 17:00

Course directors

  • Wouter van Elmpt PhD, Department of Radiation Oncology (MAASTRO), Maastricht (NL)
  • Claus Behrens PhD, Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte (DK)

Course aim

To present real-world implementations of adaptive radiotherapy. Current clinical introduction strategies for various adaptive radiotherapy approaches will be presented and discussed in detail.

Learning objectives

By the end of this course participants should:

  • Be able to understand the basics of adaptive radiotherapy in clinical practice
  • Have an overview of novel technology in clinical routine
  • Be familiarized with the particularities involved in real-world implementations
  • Appreciate possibilities for future adaptive radiotherapy approaches

Who should attend?

This course is aimed at professionals involved in the introduction of novel technology in routine clinical practice. Besides medical physicists, also radiation oncologists, radiation technologists and other health care professionals involved in introducing adaptive radiotherapy in their clinic will get an in-depth training.

Accreditation

The course has been accredited by EBAMP as CPD event for Medical Physicists at EQF Level 7 and awarded 15 CPD credit points.

Programme

Available here.